An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Department of Neurology, University of Missouri, CE515, CS & E Building, Columbia, MO, 65212, United States. Electronic address: ssd24@health.missouri.edu.
2 Department of Neurology, University of Missouri, CE515, CS & E Building, Columbia, MO, 65212, United States.
1 Department of Neurology, University of Missouri, CE515, CS & E Building, Columbia, MO, 65212, United States. Electronic address: ssd24@health.missouri.edu.
2 Department of Neurology, University of Missouri, CE515, CS & E Building, Columbia, MO, 65212, United States.
A 36-year old female with a history of generalized Myasthenia Gravis presented with…
Fig. 1
A 36-year old female with a history of generalized Myasthenia Gravis presented with worsening muscle weakness and shortness of breath. On evaluation, she was also found to be positive for SARS COV-2. She was hospitalized and treated with Plasma Exchange with her home dose of Mycophenolate Mofetil continued. Her respiratory status worsened three days after admission, showing bilateral ground glass opacities as seen in the CT chest below. Patient was intubated for 14 days before being discharged to home.
Sanders D.B. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016;87(4):419–425.
-
PMC
-
PubMed
Jacob S. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J. Neurol. Sci. 2020;412 p. 116803.
-
PMC
-
PubMed
Anand P. COVID-19 in patients with myasthenia gravis. Muscle Nerve. 2020
-
PMC
-
PubMed
Solé G. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network. Rev. Neurol. (Paris) 2020;176(6):507–515.
-
PMC
-
PubMed